El-Sokary Mohamed M M, Albreiki Hamad A, Shehata Seham F, Mahmoud Karima Gh M
Department of Theriogenology, Faculty of Veterinary Medicine, Benha University, Benha, Egypt.
Faculty of Health Sciences, Higher Colleges of Technology, Abu Dhabi, United Arab Emirates.
Front Vet Sci. 2025 Jul 2;12:1561144. doi: 10.3389/fvets.2025.1561144. eCollection 2025.
Camel oviductal isthmus aggregates provide a novel and promising model for studying sperm attachment and longevity, offering a potential alternative for short-to mid-term sperm preservation and transport under non-cryogenic conditions. Effective cryopreservation of the aggregates for later use can contribute to addressing challenges associated with camel semen preservation by potentially extending sperm lifespan and facilitating semen transport to remote areas without cryogenic facilities. Challenges in preserving the structural integrity and viability of camel oviductal aggregates remain a key critical gap during cryopreservation. This study evaluated the efficiency of vitrification protocols for camel oviductal isthmus aggregates, focusing on the effects of aggregate size, cryoprotectants (CPA), cryodevices, post-thaw viability, and sperm-binding capacity.
Aggregates retrieved from the oviductal isthmus were classified into four size groups (50, 100, 150, and 200 μm) and vitrified to determine the influence of size on post-thaw outcomes. CPA concentrations (3, 5, and 7 M) of DMSO and EG in a 1:1 ratio were tested for their impact on structural integrity and viability. The performance of cryodevices, including cryovials, 0.5 mL straws, and 0.25 mL straws, was also assessed.
The results indicated that aggregates sized 150 μm and 200 μm demonstrated superior post-thaw viability, with intactness rates of 78 ± 2.0% and 83 ± 2.8%, respectively. Among the tested CPA concentrations, 7 M showed the highest post-vitrification viability (69 ± 1.9%). Additionally, 0.25 mL straw cryodevice achieved significantly better post-thaw viability (67 ± 2.7%) compared to 0.5 mL straws (32 ± 2.1%) and cryovials (10 ± 1.1%). Regarding sperm-binding capacity post-thaw, aggregates treated with 5 M (69 sperm) and 7 M (74) CPAs showed the highest binding rates, with no significant difference between these concentrations. Further studies are required to optimize vitrification protocols to enhance the aggregate's post-vitrification viability and structural integrity.
骆驼输卵管峡部聚集体为研究精子附着和寿命提供了一种新颖且有前景的模型,为非低温条件下短期至中期的精子保存和运输提供了一种潜在的替代方法。对聚集体进行有效的冷冻保存以供后续使用,可能通过延长精子寿命和促进精液运输到没有低温设施的偏远地区,有助于应对骆驼精液保存相关的挑战。在冷冻保存过程中,保持骆驼输卵管聚集体的结构完整性和活力仍然是一个关键的关键差距。本研究评估了骆驼输卵管峡部聚集体玻璃化方案的效率,重点关注聚集体大小、冷冻保护剂(CPA)、冷冻装置、解冻后活力和精子结合能力的影响。
从输卵管峡部获取的聚集体分为四个大小组(50、100、150和200μm)并进行玻璃化处理,以确定大小对解冻后结果的影响。测试了DMSO和EG以1:1比例的CPA浓度(3、5和7M)对结构完整性和活力的影响。还评估了包括冻存管、0.5mL细管和0.25mL细管在内的冷冻装置的性能。
结果表明,大小为150μm和200μm的聚集体解冻后活力更高,完整率分别为78±2.0%和83±2.8%。在所测试的CPA浓度中,7M显示出最高的玻璃化后活力(69±1.9%)。此外,与0.5mL细管(32±2.1%)和冻存管(10±1.1%)相比,0.25mL细管冷冻装置解冻后活力显著更好(67±2.7%)。关于解冻后的精子结合能力,用5M(69个精子)和7M(74个)CPA处理的聚集体显示出最高的结合率,这些浓度之间没有显著差异。需要进一步研究优化玻璃化方案,以提高聚集体玻璃化后的活力和结构完整性。